StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note published on Sunday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Separately, HC Wainwright reaffirmed a buy rating and set a $10.00 price objective on shares of Arcadia Biosciences in a research report on Friday, April 5th.
Read Our Latest Report on RKDA
Arcadia Biosciences Stock Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last issued its quarterly earnings data on Thursday, March 28th. The basic materials company reported ($2.48) earnings per share for the quarter, beating the consensus estimate of ($2.68) by $0.20. The firm had revenue of $1.17 million for the quarter, compared to analyst estimates of $1.80 million. Arcadia Biosciences had a negative net margin of 246.80% and a negative return on equity of 81.56%. On average, sell-side analysts anticipate that Arcadia Biosciences will post -5.01 earnings per share for the current fiscal year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- What is a Low P/E Ratio and What Does it Tell Investors?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What Makes a Stock a Good Dividend Stock?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Consumer Discretionary Stocks Explained
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.